FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Iron Sucrose Injection
Status: Discontinuation
»Therapeutic Categories: Hematology

Mylan Institutional, a Viatris Company (New 05/21/2026)

Company Contact Information:
800-796-9526

Presentation	Posting Date	Related Information
Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)	05/21/2026	A business decision has been made to discontinue of 2.5mL presentation only. Continuity of supply is forecasted across all other presentations of Iron Sucrose: 67457-639-10 Iron Sucrose 20mg/mL 10mL SDV 5PK 67457-638-10 Iron Sucrose 20mg/mL 5mL SDV 10PK 67457-638-25 Iron Sucrose 20mg/mL 5mL SDV 25PK.